electroCore, Inc.
NASDAQ:ECOR

Watchlist Manager
electroCore, Inc. Logo
electroCore, Inc.
NASDAQ:ECOR
Watchlist
Price: 7.15 USD 13.67%
Market Cap: $57.2m

electroCore, Inc.
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

electroCore, Inc.
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
electroCore, Inc.
NASDAQ:ECOR
Inventory
$1.2m
CAGR 3-Years
-15%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Inventory
$2.9B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
11%
Edwards Lifesciences Corp
NYSE:EW
Inventory
$1.1B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Inventory
$5.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Inventory
$6.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Inventory
$1.8B
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
27%
No Stocks Found

electroCore, Inc.
Glance View

Market Cap
57.2m USD
Industry
Health Care

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 52 full-time employees. The company went IPO on 2018-06-22. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The firm is providing gammaCore device for the treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults. gammaCore permits patients to self-administer doses of nVNS on an as-needed basis for treatment of prevent multiple types of headache pain via the vagus nerve. The gammaCore therapy is also used to treat primary headache, including migraine, cluster headache (CH), hemicrania continua and paroxysmal hemicrania (PH) and coronavirus (COVID-19).

ECOR Intrinsic Value
7.99 USD
Undervaluation 11%
Intrinsic Value
Price

See Also

What is electroCore, Inc.'s Inventory?
Inventory
1.2m USD

Based on the financial report for Sep 30, 2025, electroCore, Inc.'s Inventory amounts to 1.2m USD.

What is electroCore, Inc.'s Inventory growth rate?
Inventory CAGR 5Y
9%

Over the last year, the Inventory growth was -38%. The average annual Inventory growth rates for electroCore, Inc. have been -15% over the past three years , 9% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett